Abstract
Background Air pollutants, particularly fine particulate matters (PM2.5) have been associated with mental disorder such as depression. Clean air policy (CAP, i.e., a series of emission-control actions) has been shown to reduce the public health burden of air pollutions. There were few studies on the health effects of CAP on mental health, particularly, in low-income and middle-income countries (LMICs). We investigated the association between a stringent CAP and depressive symptoms among general adults in China.
Methods We used three waves (2011, 2013 and 2015) of the China Health and Retirement Longitudinal Study (CHARLS), a prospective nationwide cohort of the middle-aged and older population in China. We assessed exposure to PM2.5 through a satellite-retrieved dataset. We implemented a difference-in-differences (DID) approach, under the quasi-experimental framework of the temporal contrast between 2011 (before the CAP) and 2015 (after the CAP), to evaluate the effect of CAP on depressive symptoms. The association was further explored using a mixed-effects model of the three waves. To increase the interpretability, the estimated impact of PM2.5 was compared to that of aging, an established risk factor for depression.
Findings Our analysis included 15,954 participants. In the DID model, we found a 10-μg/m3 reduction of PM2.5 concentration was associated with a 4.14% (95% CI: 0.41–8.00%) decrement in the depressive score. The estimate was similar to that from the mixed-effects model (3.63% [95% CI, 2.00–5.27%]). We also found improved air quality during 2011-2015 offset the negative impact from 5-years’ aging.
Interpretation The findings suggest that implementing CAP may improve mental wellbeing of adults in China and other LMICs.
Funding National Natural Science Foundation and Ministry of Science and Technology of China, and Energy Foundation.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Development, Peking University for providing the CHARLS data. This work was supported by National Natural Science Foundation of China (41701591, 81571130100, 81903392,and 41421064), Ministry of Science and Technology of China (2015CB553401 and 2018YFC2000400) and Energy Foundation (G1811-28843).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
IRB00001052-11015
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
The manuscript has been revised according to the peer reviews.
Data Availability
The study is based on public data.
